Globally, breast cancer cases will increase from 2.3 million in...
Category:
Health
Latest
Panda wants Bima Sugam up and running by Apr 19, 2025 coinciding with IRDAI’s 25th foundation day
Debasish Panda, chairman, IRDAI Apr 19,2025, is the 25th foundation...
EU regulator rules out link between weight-loss drugs and suicidal thoughts
The analysis started in July after Iceland's health regulator...
UK court rules under-16s can get puberty blocking drugs
Hormone blockers are drugs that can pause the development of puberty, and are sometimes prescribed to help children with gender dysphoria by giving them more time to consider their options.
Govt extends lower tax rate on COVID-19 drugs to year end
Drugs covered by the extension of lower tax rates include Zolgensma, Viltepso, Remdesivir, Favipiravir and Itolizumab.
Almost 90% of people in India’s financial capital have COVID-19 antibodies: survey
Sero-prevalence was significantly higher in individuals who had received either first or both doses of COVID-19 vaccine as compared to their unvaccinated counterparts, the survey by the Brihanmumbai Municipal Corporation (BMC) noted.
NIH grants $470 mln to conduct studies on long-term effects of COVID-19
The grant is part of an initiative the main U.S. health research body launched in February to understand why symptoms of the illness persist long after infection in some cases – a condition known as “long COVID”- and why some individuals develop new or returning symptoms after recovery.
The most common prolonged symptoms include pain, headaches and fatigue, but the condition has been linked to a higher risk of kidney problems as well as smell distortions in other studies.
More scientific data required on mixing of Covid-19 vaccine doses: Secretary Department of Biotechnology
“DCGI has given permission to CMC Vellore to start a trial on the mixing of vaccines. A couple of such studies have been initiated. We need more scientific data to get more clarity,” said Secretary, Department of Biotechnology, Government of India Dr Renu Swarup
Jitendra Singh launches AXA’s free telemedicine services in India
SAATH(Supportive Action Across Telemedicine and Healthcare) will connect people to doctors including general practitioners, ayurvedic doctors, nutritionists and Sewa International volunteers. In addition to telemedicine services, it will provide information on: availability of hospital beds and oxygen cylinders; ambulance assistance; home Intensive Care Unit setup information; food supplies for COVID-19 patients; access to psychologists; and more. Using the wide range of services, SAATH aims to increase acceptability, affordability and accessibility to telemedicine and virtual care.
Coronavirus compounds climate disasters but shows action can work- Red Cross
Almost half of 140 million people around the world, who are hit by to disasters caused by extreme weather fuelled by climate change, with more severe storms, floods, and heatwaves live in the Asia-Pacific region, the International Federation of Red Cross Red Crescent Societies (IFRC) said in a report published this week.
“Recovery from disasters is so much harder when livelihoods have been hit hard by COVID-19 and the measures taken to contain it,” said Maarten van Aalst, director of the Red Cross Red Crescent Climate Centre and author of the report.
Covid-19 pandemic had psychosocial impact on healthcare workers: ICMR study
“Manifestations of stigma have been reported in India with doctors, and nurses being forced to vacate from their premises and reports of physical violence on HCWs in many parts of the nation. This reported stress, anxiety, depression and sleep-related issues among HCWs,” the study stated.
87% of Indian cos victims of security breach last year: Report
“While organisations are adapting to the hybrid approach thinking about both working from anywhere and application hosting, they continue to experience a high level of network breaches and facing ongoing connectivity and security challenges,” Murali Urs, Country Manager, Barracuda Networks India, said in a statement.
Govt prioritising vaccinating eligible people in UP, Punjab: Report
The cumulative COVID-19 vaccine doses administered in the country crossed 78 crore on Friday. The government said 20 per cent of India’s adult population have received both doses of COVID-19 vaccine and 62 per cent have got at least one dose.
Of all the vaccines used, around 87.8 per cent are Covishield manufactured by Serum Institute, around 12.11 per cent are Bharat Biotech’s Covaxin and less than one per cent Sputnik V.